Bioengineering & Translational Medicine

Papers
(The H4-Index of Bioengineering & Translational Medicine is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Correction to “Self‐assembly of PEGPPS polymers and LL‐37 peptide nanomicelles improves the oxidative microenvironment and promotes angiogenesis to facilitate chronic220
Liver‐tumor mimics as a potential translational framework for planning and testing irreversible electroporation with multiple electrodes157
Evaluation of the efficacy and safety of ionic liquids containing ketoconazole in patients with tinea pedis: A randomized controlled clinical trial118
Polymorphic nanobody crystals as long‐acting intravitreal therapy for wet age‐related macular degeneration106
Insights into the mechanisms, regulation, and therapeutic implications of extracellular matrix stiffness in cancer99
USENSE: A proof‐of‐concept self‐screening tool for home‐based recurrent urinary tract infection management96
4D‐CT deformable image registration using unsupervised recursive cascaded full‐resolution residual networks89
Fortifying angiogenic efficacy of conditioned media using phototoxic‐free blue light for wound healing76
A soft, bioinspired artificial lymphatic system for interactive ascites transfer70
Customized flexible hollow microneedles for psoriasis treatment with reduced‐dose drug70
Disease modifying biomaterials for modulating mechanical allodynia in a preclinical model of rheumatoid arthritis70
Mitomycin C‐immobilized silver nanoparticle‐loaded polycaprolactone membrane for temporary scalp expansion after decompressive craniectomy to prevent wound infection69
Kidney organoids as a novel platform to evaluate heat‐stress‐induced acute kidney injury pathogenesis63
Revolutionizing cancer treatment: The multifaceted role of graphene oxide in modern oncology60
A high‐throughput microfluidic mechanoporation platform to enable intracellular delivery of cyclic peptides in cell‐based assays58
Novel metal peroxide nanoboxes restrain Clostridioides difficile infection beyond the bactericidal58
Bridging the gap in OA therapeutics: Bioengineered strategies to target osteoclast–chondrocyte crosstalk57
A polymer‐based systemic hemostat for managing uncontrolled bleeding56
Light controlled self‐escape capability of non‐cationic carbon nitride‐based nanosheets in lysosomes for  hepatocellular carcinoma targeting stimulus‐responsive gene delivery55
Vitrification and rapid rewarming of precision‐cut liver slices for pharmacological and biomedical research48
An in‐cell helicase reporter system for quantifying DDX3X and DDX3Y activities48
Biomimetic nanotherapeutics for targeted drug delivery to glioblastoma multiforme48
Stirred culture of cartilaginous microtissues promotes chondrogenic hypertrophy through exposure to intermittent shear stress46
Application of hydrogels in 3D tumor microenvironment modeling and drug screening for cervical cancer: A review45
Dynamic pillar–perfusion platform for screening enzyme‐induced self‐assembling peptide therapeutics in 3D breast cancer spheroids45
PEGylated thymosin β4 is a thiol‐site‐specific prodrug treating myocardial infarction in vivo45
Engineering autoimmune disease models using organoids: Harnessing microenvironmental engineering for precision medicine and immunological recapitulation44
Ultrasound‐guided interstitial photothermal therapy generates improved treatment responses in a 9464D model of neuroblastoma44
Preparation and assessment of an optimized multichannel acellular nerve allograft for peripheral nerve regeneration43
Fluidic integrated 3D bioprinting system to sustain cell viability towards larynx fabrication43
An ultralow power wearable vital sign sensor using an electromagnetically reactive near field43
Soluble CD80 oral delivery by recombinant Lactococcus suppresses tumor growth by enhancing antitumor 41
Clathrin light chain‐conjugated drug delivery for cancer40
Green/red fluorescent protein disrupting drugs for real‐time permeability tracking in three‐dimensional tumor spheroids39
Matrix metalloproteinase 2‐responsive dual‐drug‐loaded self‐assembling peptides suppress tumor growth and enhance breast cancer therapy38
Innovative myeloid ecotropic viral integration site 1‐engineered exosome platform combating oxidative stress and inflammation in acute pulmonary damage37
ROS ‐responsive robust hydrogels based on thiol‐ene click chemistry for enhancing the healing of infected wounds36
0.10300087928772